Stay updated on OBE2109 Efficacy in Heavy Menstrual Bleeding Clinical Trial
Sign up to get notified when there's something new on the OBE2109 Efficacy in Heavy Menstrual Bleeding Clinical Trial page.

Latest updates to the OBE2109 Efficacy in Heavy Menstrual Bleeding Clinical Trial page
- Check5 days agoChange DetectedThe page revision was updated to v3.5.2, replacing the previous revision v3.5.0.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision: v3.5.0 has been added and Revision: v3.4.3 has been removed.SummaryDifference0.0%

- Check34 days agoChange DetectedRemoved the term Uterine leiomyoma. Removed the Genetic and Rare Diseases Information Center resource from the resources section.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision updated to v3.4.3, replacing the previous v3.4.2. This change does not affect page content or functionality.SummaryDifference0.0%

- Check55 days agoChange DetectedAdded the term Uterine leiomyoma and a Genetic and Rare Diseases Information Center resource in the Resources section.SummaryDifference0.1%

- Check69 days agoChange DetectedAdded Revision: v3.4.2. Removed the previous Revision: v3.4.1 notice and the government funding status notice.SummaryDifference0.2%

Stay in the know with updates to OBE2109 Efficacy in Heavy Menstrual Bleeding Clinical Trial
Enter your email address, and we'll notify you when there's something new on the OBE2109 Efficacy in Heavy Menstrual Bleeding Clinical Trial page.